Table 2.
Laboratory Findings in 417 Confirmed COVID-19 Patients in the Third People's Hospital of Shenzhen from January 11 to February 18, 2020
| Variables | COVID-19 Patients |
p -value | ||
|---|---|---|---|---|
| Total | Mild-Moderate | Severe-Critical | ||
| WBC (×109/L) | 4.67 (3.79–5.83) | 4.64 (3.76–5.72) | 4.82 (3.85–5.95) | >0.99 |
| LYM (×109/L) | 1.31 (0.99–1.82) | 1.44 (1.09–1.96) | 1.02 (0.83–1.28) | <0.001 |
| NEU (×109/L) | 2.68 (2.01–3.59) | 2.55 (1.92–3.42) | 3.03 (2.28–4.39) | <0.01 |
| HGB (g/L) | 137 (127–146) | 137 (126–146) | 138 (127–151) | >0.99 |
| PLT (×109/L) | 186 (149–231) | 197 (158–241) | 151 (129–178) | <0.001 |
| CD4+ cell count | 535 (380–742) | 618 (450–805) | 334.5 (201–458) | <0.001 |
| CD8+ cell count | 350 (202–522) | 272 (417–571) | 177.5 (112–289) | <0.001 |
| CD4+/CD8+ | 1.62 (1.15–2.16) | 1.55 (1.15–1.99) | 1.83 (1.24–2.49) | 0.33 |
| D-DIC (μg/mL) | 0.36 (0.25–0.53) | 0.33 (0.24–0.47) | 0.53 (0.36–0.83) | <0.001 |
| ALT (U/L) | 21 (15–31) | 20 (13.45–28) | 26.65 (20–38) | <0.001 |
| AST (U/L) | 26 (21–35) | 25 (20–33) | 34 (26–48) | <0.001 |
| K (mmol/L) | 3.89 (3.64–4.16) | 3.90 (3.68–4.18) | 3.79 (3.54–4.09) | 0.30 |
| Na (mmol/L) | 138.5 (136.8–139.8) | 138.7 (137.3–140.0) | 136.8 (134.9–139.1) | <0.001 |
| Cr (μmol/L) | 62 (52–76) | 60 (50–74) | 72 (57–93) | <0.001 |
| eGFR (mL/min) | 105.18 (93.55–116.64) | 108.53 (97.16–118.90) | 92.50 (76.15–101.76) | <0.001 |
| CK (U/L) | 67 (51–100) | 66 (49–93) | 83 (56–170) | 0.073 |
| LDH (U/L) | 224 (176–422) | 209 (167–372) | 336 (213–592) | <0.001 |
| MYO (ng/mL) | 37.21 (27.94–53.31) | 33.02 (26.12–44.03) | 56.19 (40.63–110.16) | <0.001 |
| BNP (pg/mL) | 2.91 (0.98–8.23) | 1.74 (0.70–3.55) | 7.55 (4.32–16.32) | <0.001 |
| TnI (μg/L) | 0.005 (0.005–0.005) | 0.005 (0.005–0.005) | 0.009 (0.005–0.017) | <0.001 |
| TG (mmol/L) | 0.95 (0.73–1.31) | 0.91 (0.70–1.37) | 1.02 (0.83–1.24) | >0.99 |
| LDL (mmol/L) | 2.32 (1.91–2.78) | 2.44 (1.98–2.81) | 2.11 (1.83–2.51) | 0.96 |
| HDL (mmol/L) | 1.17 (0.97–1.39) | 1.21 (1.00–1.43) | 1.11 (0.90–1.26) | 0.33 |
| CHOL (mmol/L) | 3.96 (3.43–4.61) | 4.12 (3.57–4.65) | 3.62 (3.28–4.21) | 0.14 |
| PCT (ng/mL) | 0.039 (0.025–0.062) | 0.034 (0.023–0.052) | 0.0645 (0.049–0.088) | <0.001 |
| CRP (mg/L) | 8.7 (2.5–24.8) | 6.0 (2.2–16.5) | 27.5 (12.5–52.8) | <0.001 |
| IL-6 (pg/mL) | 11.88 (4.61–19.63) | 8.51 (3.82–16.03) | 24.17 (16.26–43.02) | <0.001 |
| ESR (mm/h) | 28 (14–45) | 23 (13–41) | 41 (24–57) | <0.001 |
p values indicate differences between mild-moderate and severe-critical patients. p < 0.05 was considered statistically significant.
WBC, white blood cells; LYM, lymphocytes; NEU, neutrophils; HGB, hemoglobin; PLT, platelets; CD4+, CD4+ T lymphocyte; CD8+, CD8+ T lymphocyte; D-DIC, D-dimer; ALT, alanine aminotransferase; AST, aspartate aminotransferase; K, potassium; Na, sodium; Cr, chromium; eGFR, estimated glomerular filtration rate; CK, creatine kinase; MYO, myoglobin; BNP, brain natriuretic peptide; TnI, troponin I; LDH, lactate dehydrogenase; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein; CHOL, cholesterol; PCT, procalcitonin; CRP, C-reactive protein; IL-6, interleukin-6; ESR, erythrocyte sedimentation rate.